Catonsville, MD, United States of America

Brian C Mansfield

USPTO Granted Patents = 5 


Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Catonsville, MD (US) (2005 - 2016)
  • Austin, TX (US) (2017 - 2020)

Company Filing History:


Years Active: 2005-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Brian C. Mansfield

Introduction

Brian C. Mansfield, an esteemed inventor based in Catonsville, MD, has made significant contributions to the field of biotechnology, particularly in cancer research. With a total of five patents to his name, Mansfield's work is characterized by innovative approaches to understanding and treating ovarian cancer.

Latest Patents

Among his most notable inventions are his latest patents focusing on predictive biomarkers for ovarian cancer. These patents provide methods for predicting the presence, subtype, and stage of ovarian cancer. They also assess the therapeutic efficacy of cancer treatments and determine whether a subject may be developing cancer. Additionally, these innovations include associated test kits, computer and analytical systems, as well as software and diagnostic models, making them comprehensive tools for both diagnosis and treatment evaluation.

Career Highlights

Brian C. Mansfield has built an impressive career in the biotechnology sector, with significant roles at leading companies such as Vermillion Corporation and Human Genome Sciences, Inc. His experience in these organizations has allowed him to spearhead advancements in cancer diagnostics and treatment strategies.

Collaborations

Throughout his career, Mansfield has collaborated with notable individuals, including Ping F. Yip and Suraj Amonkar. These partnerships have fostered a dynamic environment for innovation and have greatly influenced the development of his patents and research initiatives.

Conclusion

Brian C. Mansfield continues to be a pivotal figure in the field of cancer research. His patents not only demonstrate his innovative capabilities but also hold promise for improving patient outcomes in ovarian cancer. As he advances his work, the implications of his research will undoubtedly contribute to further innovations in medical diagnostics and therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…